Anti-ABI2 antibody [EPR3906] (ab108340)
- Datasheet
- Specific References (1)
- Protocols
Overview
-
Product nameAnti-ABI2 antibody [EPR3906]
See all ABI2 primary antibodies -
DescriptionRabbit monoclonal [EPR3906] to ABI2
-
Host speciesRabbit
-
Tested applicationsSuitable for: WB, IP, IHC-P, ICCmore details
Unsuitable for: Flow Cyt -
Species reactivityReacts with: Mouse, Rat, Human
-
Immunogen
Synthetic peptide corresponding to a region within in Human ABI2.
-
Positive control
- HeLa, Jurkat, K562, SH-SY5Y and HepG2 cell lysates. Paraffin-embedded Human brain tissue.
-
General notes
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
-
Storage bufferPBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
-
PurityTissue culture supernatant
-
ClonalityMonoclonal
-
Clone numberEPR3906
-
IsotypeIgG
-
Research areas
Associated products
-
Positive Controls
Applications
Our Abpromise guarantee covers the use of ab108340 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB | 1/1000 - 1/10000. Predicted molecular weight: 57 kDa. | |
| IP | 1/10 - 1/100. | |
| IHC-P | 1/250 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. | |
| ICC | 1/500 - 1/1000. |
Target
-
FunctionMay act in regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex. Regulates ABL1/c-Abl-mediated phosphorylation of MENA.
-
Sequence similaritiesBelongs to the ABI family.
Contains 1 SH3 domain.
Contains 1 t-SNARE coiled-coil homology domain. -
Post-translational
modificationsIs a substrate for ABL1. -
Cellular localizationCytoplasm and Cell projection > lamellipodium. Cell projection > filopodium. Cytoplasm > cytoskeleton. Isoform 1 but not isoform 3 is localized to protruding lamellipodia and filopodia tips.
- Information by UniProt
-
Database links
- Entrez Gene: 10152 Human
- Entrez Gene: 329165 Mouse
- Entrez Gene: 286928 Rat
- Omim: 606442 Human
- SwissProt: Q9NYB9 Human
- SwissProt: P62484 Mouse
- Unigene: 471156 Human
- Unigene: 212066 Mouse
see all -
Alternative names
- Abelson interactor 2 antibody
- ABI 2 antibody
- Abi-2 antibody
see all
Images
-
![Western blot - Anti-ABI2 antibody [EPR3906] (ab108340)](http://a.abcam.com/ps/products/108/ab108340/Images/ab108340-203621-ab108340wb.jpg)
Western blot - Anti-ABI2 antibody [EPR3906] (ab108340)This image is courtesy of an anonymous AbreviewWestern blot analysis of Human fibroblast cell lysates (15μg/lane) labelling ABI2 with ab108340 at 1:1000. A Dyomics® 647-conjugated Goat anti-rabbit IgG monoclonal (1:5000) was used as the secondary antibody.
-
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - ABI2 antibody [EPR3906] (ab108340)](http://a.abcam.com/ps/datasheet/images/108/ab108340/ABI2-Primary-antibodies-ab108340-2.jpg)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - ABI2 antibody [EPR3906] (ab108340)ab108340, at 1/250, staining ABI2 in paraffin-embedded Human brain tissue by Immunohistochemistry. -
![Immunocytochemistry/ Immunofluorescence - ABI2 antibody [EPR3906] (ab108340)](http://a.abcam.com/ps/datasheet/images/108/ab108340/ABI2-Primary-antibodies-ab108340-3.jpg)
Immunocytochemistry/ Immunofluorescence - ABI2 antibody [EPR3906] (ab108340)ab108340, at 1/500, staining ABI2 in HeLa cells by Immunofluorescence.
Protocols
References
This product has been referenced in:
- Crawford LJ et al. Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models. Oncogenesis 3:e90 (2014). WB ; Human . Read more (PubMed: 24590311) »
Customer reviews and Q&As
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"